HOHologic HOLX · NASDAQ
$76.01 +0.00% (+$0.00)
- Market cap
- $17.0B
- Enterprise value
- $17.6B
- P/E
- 30.6x
- Forward P/E
- -
- PEG
- -
- P/S
- 4.1x
- P/FCF
- 18.1x
- EV/EBITDA
- 16.3x
- ROIC
- 7.3%
- Gross margin
- 53.0%
- Net margin
- 13.8%
- Dividend yield
- -
- Payout ratio
- -
- Net debt/EBITDA
- 0.6x
- Beta
- 0.70
- Free float
- 99.1%
About the company
Hologic, Inc. (HOLX) is an American company operating in the field of medical technologies and diagnostic solutions. The company specializes in the development, manufacturing, and sale of innovative medical devices and diagnostic tests for women's health. Its products include mammography systems, devices for osteoporosis diagnosis, cytology and molecular diagnostic systems, among others. Hologic holds a strong market position in women's health and is known for its advanced technologies and high-quality diagnostic solutions. The company focuses on providing innovative tools and technologies that enable early detection and diagnosis of diseases, contributing to the improvement of patients' health outcomes. Investors seeking exposure to the healthcare sector and technologies for women's health may consider shares of Hologic, Inc. (HOLX) as an interesting investment opportunity.
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Paul Malenchini
Employees
7,063
Headquarters
Marlborough
Valuation
Is today's price reasonable?
Growth and estimates
Is it growing, and what comes next?
Profitability and quality
How much of the revenue is left, and how well does the company use its capital?
Financial health
Can it carry its debt?
Capital and dividends
What does the company do with the money it earns?
Analysts
What do the professionals think, and is it changing?
Owners and insiders
Who holds the stock, and what is management doing?
Segments
Which part of the company is growing?
Peer comparison
How does it compare with similar companies?
Price and risk
How does the stock behave?
Statements
Every number